pharma · Alzheimer Disease · Pulmonary Fibrosis
Shanghai University of
Shanghai University of Traditional Chinese Medicine
Shanghai University of clinical programs — 9 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Shanghai, China, CN
- Employees
- 6
- Programs
- 24
- Drugs
- 33
- Patents
- 0
Shanghai University of projects
9 ClinicalTrials.gov programs sponsored by Shanghai University of.
Shanghai University of has 9 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
AK0529
Shanghai University of Traditional Chinese Medicine
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
1 trial -
EMB-01
Shanghai University of Traditional Chinese Medicine
Neoplasms
1 trial -
Furmonertinib
Shanghai University of Traditional Chinese Medicine
Lung Adenocarcinoma Stage III
1 trial -
JMT108
Shanghai University of Traditional Chinese Medicine
Unresectable Locally Advanced or Metastatic Melanoma
1 trial -
MRG003
Shanghai University of Traditional Chinese Medicine
Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
1 trial -
SR419
Shanghai University of Traditional Chinese Medicine
Peripheral Neuropathic Pain
1 trial -
TQC2731 injection
Shanghai University of Traditional Chinese Medicine
Chronic Obstructive Pulmonary Disease
1 trial -
TQH2722 injection
Shanghai University of Traditional Chinese Medicine
Seasonal Allergic Rhinitis
1 trial -
cis Platinum/Carboplatin, Pemetrexed Disodium
Shanghai University of Traditional Chinese Medicine
Chemotherapy, Adjuvant
1 trial
Frequently asked questions
How many clinical projects does Shanghai University of have?
9 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.